In addition, there was no significant increase in mortality or LV rupture in the Fbln7−/−‐MI compared with the Fbln7+/+‐MI group, suggesting that FBLN7 deletion could ameliorate post‐MI adverse remodeling without impairing infarct healing. This evidence concerns the gene FBLN7 and myocardial infarction.